These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36121489)

  • 21. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.
    Namasivayam S; Maiga M; Yuan W; Thovarai V; Costa DL; Mittereder LR; Wipperman MF; Glickman MS; Dzutsev A; Trinchieri G; Sher A
    Microbiome; 2017 Jul; 5(1):71. PubMed ID: 28683818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in plasma proteomes for active tuberculosis, latent tuberculosis and non-tuberculosis mycobacterial lung disease patients with and without ESAT-6/CFP10 stimulation.
    Teklu T; Wondale B; Taye B; Hailemariam M; Bekele S; Tamirat M; Zewude A; Mohamed T; Medhin G; Legesse M; Yu Y; Ameni G; Pieper R
    Proteome Sci; 2020 Oct; 18(1):10. PubMed ID: 33292280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota composition can reflect immune responses of latent tuberculosis infection in patients with poorly controlled diabetes.
    Huang HL; Luo YC; Lu PL; Huang CH; Lin KD; Lee MR; Cheng MH; Yeh YT; Kao CY; Wang JY; Yang JM; Chong IW
    Respir Res; 2023 Jan; 24(1):11. PubMed ID: 36631857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing.
    Cheung MK; Lam WY; Fung WY; Law PT; Au CH; Nong W; Kam KM; Kwan HS; Tsui SK
    PLoS One; 2013; 8(1):e54574. PubMed ID: 23365674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in the Gut Microbiome of Individuals With Tuberculosis of Different Disease States.
    Wang Y; Deng Y; Liu N; Chen Y; Jiang Y; Teng Z; Ma Z; Chang Y; Xiang Y
    Front Cell Infect Microbiol; 2022; 12():836987. PubMed ID: 35425720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study.
    Shi W; Hu Y; Zheng X; Ning Z; Wu M; Xia F; Prast-Nielsen S; Hu YOO; Xu B
    BMC Pulm Med; 2019 Nov; 19(1):211. PubMed ID: 31711450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of the lung microbiota in pulmonary tuberculosis.
    Hong BY; Paulson JN; Stine OC; Weinstock GM; Cervantes JL
    Tuberculosis (Edinb); 2018 Mar; 109():102-108. PubMed ID: 29559113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of tuberculosis disease on human gut microbiota: a systematic review.
    Baral T; Kurian SJ; Thomas L; Udyavara Kudru C; Mukhopadhyay C; Saravu K; Manu MK; Singh J; Munisamy M; Kumar A; Khandelwal B; Rao M; Sekhar Miraj S
    Expert Rev Anti Infect Ther; 2023 Feb; 21(2):175-188. PubMed ID: 36564016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiome in sputum as a potential biomarker of chronicity in pulmonary resistant to rifampicin-tuberculosis and multidrug-resistant-tuberculosis patients.
    Wiqoyah N; Mertaniasih NM; Artama WT; Matsumoto S
    Int J Mycobacteriol; 2021; 10(3):260-267. PubMed ID: 34494564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sputum microbiota associated with new, recurrent and treatment failure tuberculosis.
    Wu J; Liu W; He L; Huang F; Chen J; Cui P; Shen Y; Zhao J; Wang W; Zhang Y; Zhu M; Zhang W; Zhang Y
    PLoS One; 2013; 8(12):e83445. PubMed ID: 24349510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in mice.
    Negi S; Pahari S; Bashir H; Agrewala JN
    Eur J Immunol; 2020 Dec; 50(12):1976-1987. PubMed ID: 32673409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gut microbiome: A line of defense against tuberculosis development.
    Yu Z; Shen X; Wang A; Hu C; Chen J
    Front Cell Infect Microbiol; 2023; 13():1149679. PubMed ID: 37143744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The human microbiota in pulmonary tuberculosis: Not so innocent bystanders.
    Tarashi S; Ahmadi Badi S; Moshiri A; Nasehi M; Fateh A; Vaziri F; Siadat SD
    Tuberculosis (Edinb); 2018 Dec; 113():215-221. PubMed ID: 30514505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis.
    Nenadić N; Kirin BK; Letoja IZ; Plavec D; Topić RZ; Dodig S
    Pediatr Pulmonol; 2012 Apr; 47(4):401-8. PubMed ID: 21901862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients.
    Hu Y; Feng Y; Wu J; Liu F; Zhang Z; Hao Y; Liang S; Li B; Li J; Lv N; Xu Y; Zhu B; Sun Z
    Front Cell Infect Microbiol; 2019; 9():90. PubMed ID: 31001490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.